Loading...

SI-BONE, Inc.

SIBN•NASDAQ
Healthcare
Medical - Devices
$17.75
$0.50(2.93%)

SI-BONE, Inc. (SIBN) Stock Overview

Explore SI-BONE, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 69.9/100

Key Financials

Market Cap750M
P/E Ratio-27.78
EPS (TTM)$-0.63
ROE-0.16%
Fundamental Analysis

AI Price Forecasts

1 Week$18.63
1 Month$18.72
3 Months$15.09
1 Year Target$14.36

SIBN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of SI-BONE, Inc. (SIBN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.84, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $14.36.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -27.78 and a market capitalization of 750M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;